Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 15,000 shares at $30.21 ($448K) on 2021-08-10, disclosed to the SEC on 2021-08-11.
Open-market sale of $448k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.74 | 5,620 | $167K | 37.3% |
| 2 | $29.74 | 5,620 | $167K | 37.3% |
| 3 | $30.21 | 1,880 | $57K | 12.7% |
| 4 | $30.21 | 1,880 | $57K | 12.7% |
| Total | $29.86 avg | 15,000 | $448K | 100% |
| Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |
| NRIX | SELL | 2021-03-09 | $548K | — | Filing → |